Michael Schmertzler

Michael Schmertzler

Président chez PTC THERAPEUTICS, INC.

Fortune : 171 M $ au 31/05/2026

74 ans
Finance
Health Technology
Consumer Services

Profil

Michael Schmertzler is currently Chairman at PTC Therapeutics, Inc. since 2004, Director at Dispel LLC, Managing Director and Co-Head at CSFB Private Equity Partners LLC, Director at The LOR Foundation, Inc., Director at AgNovos Healthcare LLC, Director at Berryville Holdings LLC since 2014, Director at SHY Therapeutics LLC since 2015, and Trustee at Phillips Academy Andover since 2021.
Former roles include Chief Executive Officer & Director at Kolltan Pharmaceuticals, Inc. in 2012, Director at Coltec Industries, Inc., Director at Idenix Pharmaceuticals LLC, Director at Cytokinetics, Inc. from 2003 to 2010, Director at Segway, Inc., Independent Director at Lehman Commercial Paper, Inc., Director at New York Academy of Sciences, Director at Manhattan Theatre Club, Inc., Managing Director & Chief Financial Officer at Lehman Brothers, Kuhn, Loeb, Inc., Managing Director at Aries Advisors LLC from 2001 to 2015, Director at Colt Industries, Inc., Director at National Outdoor Leadership School, Director at Cain Chemical, Inc., Director at Credit Suisse Americas Foundation, Director at The Addison Gallery of American Art, Head-International Sales & Trading at Lehman Brothers, Inc., Senior Manager-Institutional Private Equity at Credit Suisse First Boston Equity Partners LP from 1986 to 2001, Principal at Credit Suisse First Boston LLC in 2001, President at Morgan Stanley Leveraged Capital Fund, Inc., and Head-International Investment Banking at Shearson Lehman Brothers, Inc. Education includes an MBA from Harvard Business School and an undergraduate degree from Yale College conferred in 1998.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
1,43 %
31/03/2025 625 005 ( 1,43 % ) 54 M $ 31/05/2026
2,2 %
27/05/2026 600 000 ( 2,2 % ) 52 M $ 31/05/2026
4,93 %
04/09/2025 600 000 ( 4,93 % ) 52 M $ 31/05/2026
10/04/2026 163 269 ( 0,2 % ) 12 M $ 31/05/2026

Postes actifs de Michael Schmertzler

SociétésPosteDébut
PTC THERAPEUTICS, INC. Président 01/11/2004
Directeur/Membre du Conseil -
Directeur/Membre du Conseil -
SHY Therapeutics LLC
Directeur/Membre du Conseil 01/06/2015
Directeur/Membre du Conseil 01/06/2014
Directeur/Membre du Conseil -
Directeur/Membre du Conseil -
Private Equity Investor -

Anciens postes connus de Michael Schmertzler

SociétésPosteFin
Aries Advisors LLC
Corporate Officer/Principal 01/01/2015
░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░
░░░░░░░░░░░░░ ░░░░░░░░░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░░░░░
░░░░░░ ░░░░░░ ░░░░░ ░░░░░░ ░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░░ ░░░░░░ ░░░░░ ░░░░░░ ░░░░░░ ░░░░░░░░ ░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
Voir l'expérience en détail de Michael Schmertzler

Formation de Michael Schmertzler

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

69

Relations au 1er degré

30

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées30

Electronic Technology

Finance

Health Technology

Health Technology

Finance

Health Technology

Finance

Consumer Durables

Health Technology

Finance

Finance

Morgan Stanley Leveraged Capital Fund, Inc.

Commercial Services

Consumer Services

Finance

Aries Advisors LLC

Consumer Durables

Commercial Services

Process Industries

Credit Suisse Americas Foundation

Consumer Services

Shearson Lehman Brothers, Inc.

Finance

Consumer Services

Consumer Services

Health Technology

Technology Services

The Addison Gallery of American Art

Health Services

Technology Services

SHY Therapeutics LLC

  1. Bourse
  2. Insiders
  3. Michael Schmertzler
- 40% : Les Meilleurs Outils Réservés aux Abonnés pour Identifier les Meilleurs Investissements de Demain !
j
:
:
PROFITEZ-EN MAINTENANT
🔇